OFTY › Glaucoma

Clinical Decision Support · Glaucoma

Glaucoma Clinical
Decision Tools

Evidence-informed tools for IOP contextualisation, target pressure estimation, and functional and structural progression analysis — designed for the consulting room, not the classroom.


OFTY Glaucoma Suite

A modular clinical reasoning framework for structured interpretation of glaucoma monitoring parameters — covering IOP contextualisation, individualized target pressure estimation, functional and structural progression analysis, and integrated cross-module synthesis.

M1 v1.1 M1 Advanced v0.4

IOP + CCT Contextualizer

M1 provides a GAT/CCT contextual IOP estimate using the standard OFTY Core model. The new Advanced mode adds ORA / Corvis biomechanical context while keeping each measurement domain separate.

M2 v1.1

Target IOP Calculator

Estimates a personalised target IOP range by integrating glaucoma type, disease stage, corneal thickness category, and progression status. Works with or without a documented baseline pressure, adapting its estimation logic accordingly.

Open tool
M3 v1.1

Functional Progression Analysis

Analyses longitudinal visual field MD slope using linear regression and a multi-gate rule-based algorithm — generating one of four structured outcomes: Stable, Suspicious trend, Progressing, or Not assessable.

Open tool
M4 v1.1

Structural Progression Analysis

Analyses longitudinal RNFL thinning rates from OCT data using linear regression and a hierarchical rule cascade — generating one of five structured outcomes: Stable, Suspicious trend, Progressing, Signal limited, or Not assessable.

Open tool
M5 Orchestrator v1.2

Integrated Clinical Synthesis

Combines the outputs of M1–M4 into a unified structural–functional interpretation contextualised by pressure status. Classifies six clinical patterns — including concordant progression and structural-functional discordance — and applies confidence adjustments for floor effects, signal limitations, and incomplete data.

Three-layer integration 215/215 verification configurations Requires M1–M4 outputs
Open Orchestrator

How these tools think

Stage-based thinking Risk modifier awareness Always individualised Progression-aware

Glaucoma management is fundamentally about weighing risk against burden of treatment for each individual patient. These tools are built around that principle — they do not produce a single answer, but a structured, evidence-referenced starting point for clinical reasoning.

IOP remains the primary modifiable risk factor, but it cannot be read in isolation. Corneal thickness, optic nerve appearance, visual field trajectory, age, and systemic factors all shape what a given pressure means for a given patient. The tools here are designed to surface those contextual layers quickly and transparently.

Importantly, CCT is used to compute a contextualised IOP estimate — applying a simplified linear correction model while simultaneously flagging the interpretative limitations of the adjustment. The output is not a definitive corrected value but a structured starting point for clinical interpretation, in line with current evidence and major guideline recommendations (EGS, AAO).

All outputs must be reassessed in light of disease progression, new clinical findings, and the complete picture of the individual patient. These tools assist judgment — they do not replace it.


Disclaimer

OFTY tools provide decision support only and do not constitute medical advice. All clinical decisions must be individualised by a qualified clinician.

  • These tools are for decision support only. They do not replace clinical examination, professional judgment, or individualised patient assessment.
  • All outputs must be interpreted in the full clinical context of each patient.
  • CCT values are used to compute a contextualised IOP estimate and to flag tonometric reliability — the adjusted value is presented with explicit interpretative cautions, not as a definitive corrected pressure, in line with current evidence and major guideline recommendations (EGS, AAO).
  • Clinical situations evolve. Always reassess in light of disease progression, new findings, and the overall clinical picture.
  • OFTY does not store patient data and is not a certified medical device.